Haem oxygenase-1 and cardiovascular disease: mechanisms and therapeutic potential

Kim H Chan1, Martin K C Ng, Roland Stocker

  • 1Department of Cardiology, Royal Prince Alfred Hospital, Camperdown, NSW 2050, Australia.

Insights

Heme oxygenase-1 (HO-1) offers protective vascular benefits against cardiovascular disease (CVD). Inducing HO-1 presents a novel therapeutic strategy for managing CVD, particularly for patients ineligible for current treatments.

Area of Science:

  • Biochemistry
  • Cardiology
  • Molecular Biology

Background:

  • Cardiovascular disease (CVD) is the leading global cause of mortality.
  • Current CVD treatments do not benefit all patients.
  • Heme oxygenase-1 (HO-1) was traditionally viewed as metabolic but now shows protective roles under stress.

Purpose of the Study:

  • To review the mechanisms of HO-1 in vascular protection.
  • To highlight HO-1's atheroprotective, anti-inflammatory, and antioxidative properties.
  • To examine HO-1's role in vascular repair and CVD management.

Main Methods:

  • Literature review of HO-1's functions in vascular health.
  • Analysis of evidence from animal and human studies on HO-1 in CVD.
  • Exploration of therapeutic strategies targeting HO-1 induction.

Main Results:

  • HO-1 exhibits significant atheroprotective, anti-inflammatory, and antioxidative effects.
  • HO-1 plays a crucial role in vascular repair mechanisms.
  • Studies confirm HO-1's protective effects in both preclinical and clinical CVD models.

Conclusions:

  • HO-1 possesses multifaceted protective activities beneficial for vascular health.
  • Targeting HO-1 induction represents a promising novel therapeutic avenue for CVD.
  • HO-1 offers potential for vascular protection and repair in managing cardiovascular disease.

Related Concept Videos

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure01:16

Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure

Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue, improving...
Pulmonary Hypertension: Classification and Pathogenesis01:30

Pulmonary Hypertension: Classification and Pathogenesis

Pulmonary hypertension (PH) is a severe health condition in which the mean pulmonary arterial pressure increases to 25 mmHg or more, even when the body is at rest. This high pressure in the blood vessels that transport blood from the heart to the lungs can cause various symptoms, including shortness of breath, can lead to right heart failure, and significantly affect the overall quality of life.
There are various classifications for PH, each relating to different underlying causes and also...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
Physiological Control of Respiration01:23

Physiological Control of Respiration

Introduction
Breathing, a seemingly passive process, is regulated by the respiratory center in the brainstem. This center coordinates the involuntary control of respirations, which means it occurs without conscious effort, ensuring a smooth and uninterrupted pattern.
Regulation of Ventilation
The body maintains ventilation by monitoring levels of carbon dioxide (CO2), oxygen (O2), and hydrogen ion concentration (pH) in the arterial blood. Among these factors, the level of CO2 plays a crucial...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...